this study assessed in 1,330 patients followed up for 292 +/- 393 days the predictive value for cardiovascular safety of a system by which patients were classified according to ventricular arrhythmias on entry , presence or absence of organic heart disease and drug dose for flecainide acetate .
C0007226
cardiovascular
C0085612
ventricular arrhythmias